Experiments

Searchable full-text extractions: founding hypothesis, core claims, experimental setups, key results and statistics — pulled out of each paper as structure. Search a cell line, an assay or an entity (e.g. HUH7) and find every paper that worked with it. This corpus stands on its own: most entries carry no reproduction assessment (yet).

• Lipid droplet-mediated macrophage reprogramming drives fibroblast activation in keloid-associated inflammation.

  PMID 41840659 · PMC13063924 · Cell communication and signaling : CCS · 2026 · 8 claims · 8 setups

  Full-text index only

  Keloid-associated macrophages (KAM) and skin-associated macrophages (SAM) represent transcriptionally distinct populations, with KAM showing enhanced lipid metabolism and M2/pro-fibrotic signatures

  skin keloid pbmc-derived macrophages single-cell immunofluorescence macrophage-sebocyte

• The butyrophilin 1a1 knockout mouse revisited: Ablation of Btn1a1 leads to concurrent cell death and renewal in the mammary epithelium during lactation.

  PMID 34938960 · PMC8664049 · FASEB bioAdvances · 2021 · 8 claims · 8 setups

  Has reproduction · 98

  BTN1A1 functions as an apical membrane receptor that forms a lipid-droplet secretion complex with the redox enzyme xanthine oxidoreductase (XDH)

  mammary rna-seq proteomic qrt-pcr

• Anesthetics impact the resolution of inflammation.

  PMID 18382663 · PMC2268966 · PloS one · 2008 · 8 claims · 8 setups

  Full-text index only

  Lidocaine delays and blocks key events in the resolution of acute inflammation

  peritoneal cell-free zymosan-induced lipid apoptosis

• Purinergic adipocyte-macrophage crosstalk promotes degeneration of thermogenic brown adipose tissue.

  PMID 41261284 · PMC12715258 · EMBO reports · 2025 · 8 claims · 8 setups

  Has reproduction · 78

  Imbalanced sympathetic/thermogenic activation (via UCP1 deficiency or pharmacological futile thermogenesis) causes BAT inflammation, fibrosis and degeneration

  bat wild-type brown histology qrt-pcr norepinephrine

• Disruption of metabolic licensing by JAK inhibitors constrains CD8 T cell activation and effector function.

  PMID 41876467 · PMC13039990 · Cell death & disease · 2026 · 8 claims · 8 setups

  Full-text index only

  JAKis targeting JAK1, JAK1/2, or JAK1/3 markedly reduce CD8 T cell activation markers, proliferation, and effector molecule (TNF, granzyme B) production

  naive memory activated sorted flow scenith cd8